W-SUDs for COVID-19

PHASE1CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Substance Use DisordersAlcohol Use Disorder
Interventions
OTHER

Woebot Substance Use Disorder

Woebot Substance Use Disorder is an automated conversational agent, available through a smartphone application, that delivers evidence-based psychotherapeutics, empathy, and emotional health psychoeducation.

Trial Locations (1)

94306

Stanford University, Palo Alto

All Listed Sponsors
collaborator

Stanford University

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Woebot Health

INDUSTRY

NCT04460027 - W-SUDs for COVID-19 | Biotech Hunter | Biotech Hunter